Le Lézard
Classified in: Health, Business
Subject: PER

Hammes Company welcomes Raymond Scheller as regional vice president

MILWAUKEE, Jan. 16, 2020 /PRNewswire-PRWeb/ -- Hammes Company, the nation's leading healthcare developer as ranked by Modern Healthcare's Construction and Design Survey, is pleased to announce that Raymond Scheller has joined the firm as regional vice president for the Midwest. He will be based out of Hammes Company's headquarters in Milwaukee, Wisconsin.

Scheller, an architect by trade, brings more than 27 years of healthcare facility planning, design and construction experience. Prior to joining Hammes Company, he was the vice president of planning, design and construction for Bon Secours Mercy Health where he provided systemwide leadership across seven states. While at Bon Secours, Scheller was a member of the merger integration team for planning, design and construction and led systemwide infrastructure assessment and capital planning programs. Over his career, he has led the planning and investment of more than $2 billion in healthcare capital projects.

"We are thrilled to welcome Ray to Hammes Company," said Hammes Company President Nancy Connolly. "Having worked on the owner's side for one of the nation's largest health systems, Ray brings a unique and incredibly valuable perspective to our clients and our team."

Scheller is a licensed architect and received a Bachelor of Architecture from the University of Kentucky.


SOURCE Hammes Company

These press releases may also interest you

at 10:15
The "Antimicrobial Food Disinfectant Market - Global Outlook & Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Antimicrobial...

at 10:15
Americans are responding to the challenges posed by the COVID-19 pandemic by making positive lifestyle changes that they expect to continue long term, according to a national survey by Parade/Cleveland Clinic. The third annual Healthy Now poll shows...

at 10:10
According to Coherent Market Insights, the global neurofibromatosis treatment drugs market is estimated to be valued at US$ 8,801.0 million in 2020 and is expected to exhibit a CAGR of 13.4% during the forecast period (2020-2027). Key Trends and...

at 10:07
Health Canada has granted approval for the Hyris bCUBE to be used as a medical device for COVID-19 human testing. As a portable device, the Hyris bCUBE provides onsite and accurate results in minutes. This timely approval arrives as Canadians face...

at 10:05
Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, is pleased to announce and welcome Mary Dennehy as Vice President of Marketing. Mary will be responsible for driving the development and...

at 10:05
The "Global Neutropenia Treatment Market By Distribution channel, By Treatment, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering. The global neutropenia treatment market size is...

News published on 16 january 2020 at 12:40 and distributed by: